Cart
sales@molnova.com
Decarboxy Moxifloxacin
CAS No. 1322062-57-6
Decarboxy Moxifloxacin( —— )
Catalog No. M26147 CAS No. 1322062-57-6
Decarboxylated moxifloxacin is a decarboxylated compound of moxifloxacin.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 89 | In Stock |
|
| 5MG | 82 | In Stock |
|
| 10MG | 122 | In Stock |
|
| 25MG | 204 | In Stock |
|
| 50MG | 298 | In Stock |
|
| 100MG | 423 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDecarboxy Moxifloxacin
-
NoteResearch use only, not for human use.
-
Brief DescriptionDecarboxylated moxifloxacin is a decarboxylated compound of moxifloxacin.
-
DescriptionDecarboxylated moxifloxacin is a decarboxylated compound of moxifloxacin. Moxifloxacin is an oral active 8-methoxy quinolone antibiotic used in acute bacterial sinusitis, chronic bronchitis, acute bacterial deterioration, and community-acquired pneumonia.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorTrk
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1322062-57-6
-
Formula Weight357.429
-
Molecular FormulaC20H24FN3O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[H][C@]12CN(C[C@@]1([H])NCCC2)c1c(F)cc2c(c1OC)n(ccc2=O)C1CC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Ladanetin-6-O-β-D-gl...
Ladanetin-6-O-β-D-glucopyranoside is an active flavonoid. Ladanetin-6-O-β-D-glucopyranoside has antioxidative effect. Ladanetin-6-O-β-D-glucopyranoside can be used for the research of cardioprotective effects.
-
D-Ornithine monohydr...
Used as pharmaceutical intermediates.
-
Egg yolk phosphatidy...
Lecithins, egg can be used as an excipient. Pharmaceutical excipients, or pharmaceutical auxiliaries, refer to other chemical substances used in the pharmaceutical process other than pharmaceutical ingredients. Pharmaceutical excipients generally refer to inactive ingredients in pharmaceutical preparations, which can improve the stability, solubility and processability of pharmaceutical preparations. Pharmaceutical excipients also affect the absorption, distribution, metabolism, and elimination (ADME) processes of co-administered drugs.
